Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-04

Clinical Trial Update: Methylene Blue in Early Septic Shock [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates on methylene blue for septic shock have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Hospital Civil de Guadalajara | Conditions: Septic Shock | Phase 2, Phase 3 | Status: COMPLETED